Abstract:<h3 class="a-plus-plus">Abstract</h3> <p class="a-plus-plus">Over the last two decades, mass spectrometry imaging (MSI) has been increasingly employed to investigate the spatial distribution of a wide variety of molecules in complex biological samples. MSI has demonstrated its potential in numerous applications from drug discovery, disease state evaluation through proteomic and/or metabolomic studies. Significant technological and methodological advancements have addressed natural limitations of the techniques, <em class="a-plus-plus">i.e.</em>, increased spatial resolution, increased detection sensitivity especially for large molecules, higher throughput analysis and data management. One of the next major evolutions of MSI is linked to the introduction of imaging mass cytometry (IMC). IMC is a multiplexed method for tissue phenotyping, imaging signalling pathway or cell marker assessment, at sub-cellular resolution (1 μm). It uses MSI to simultaneously detect and quantify up to 30 different antibodies within a tissue section. The combination of MSI with other molecular imaging techniques can also provide highly relevant complementary information to explore new scientific fields. Traditionally, classical histology (especially haematoxylin and eosin–stained sections) is overlaid with molecular profiles obtained by MSI. Thus, MSI-based molecular histology provides a snapshot of a tissue microenvironment and enables the correlation of drugs, metabolites, lipids, peptides or proteins with histological/pathological features or tissue substructures. Recently, many examples combining MSI with other imaging modalities such as fluorescence, confocal Raman spectroscopy and MRI have emerged. For instance, brain pathophysiology has been studied using both MRI and MSI, establishing correlations between in and <em class="a-plus-plus">ex vivo</em> molecular imaging techniques. Endogenous metabolite and small peptide modulation were evaluated depending on disease state. Here, we review advanced ‘hot topics’ in MSI development and explore the combination of MSI with established molecular imaging techniques to improve our understanding of biological and pathophysiological processes.</p>

Spatial pharmacology using mass spectrometry imaging

Mass Spectrometry Imaging for Spatial Toxicology Research

From molecules to visuals: Empowering drug discovery and development with mass spectrometry imaging

Recent Advances in Mass Spectrometry-Based Spatially Resolved Molecular Imaging of Drug Disposition and Metabolomics

Mass Spectrometry Imaging: Applications in Drug Distribution Studies

Future technology insight: mass spectrometry imaging as a tool in drug research and development

Mass spectrometry imaging and its application in pharmaceutical research and development: A concise review

Spatially resolved metabolomics: From metabolite mapping to function visualising

High spatial resolution mass spectrometry imaging for spatial metabolomics: Advances, challenges, and future perspectives

Spatial metabolomics principles and application to cancer research

State-of-the-art application of mass spectrometry imaging covering the medicinal and edible plants

Recent advancement and applications of mass spectrometry imaging

Advances in mass spectrometry imaging for spatial cancer metabolomics.

Frontiers in Mass Spectrometry-Based Spatial Metabolomics: Current Applications and Challenges in the Context of Biomedical Research

Expanding Spatial Metabolomics Coverage with Lithium-Doped Nanospray Desorption Electrospray Ionization Mass Spectrometry Imaging

Advances in mass spectrometry imaging for toxicological analysis and safety evaluation of pharmaceuticals

Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues

Mass spectrometry imaging: new eyes on natural products for drug research and development

Quantitative Mass Spectrometry Imaging: Therapeutics & Biomolecules

Spatial proteomics in three-dimensional intact specimens

Accelerating Drug Development Using Spatial Multi-omics